Oncogenic viruses are responsible for approximately 20% of cancers globally, making their surveillance a critical public health challenge. Viruses such as human papillomavirus (HPV), hepatitis B and C viruses, and certain human polyomaviruses play central roles in initiating cancerous transformations in infected hosts. Unfortunately, because these viruses often lead to asymptomatic infections that may persist for years or even decades, their detection before malignancy arises remains difficult. Dr. Anthony Maresso, a molecular virologist at Baylor, highlights that traditional clinical approaches to identify such infections often lag behind, limiting early intervention strategies. Inspired by successes in viral wastewater analysis, his team explored whether similar surveillance could extend to monitoring oncogenic viruses community-wide.

Wastewater presents an untapped reservoir of viral genetic material shed by individuals through urine, feces, and skin cells that ultimately aggregate in sewage systems. By employing advanced genetic sequencing on these samples, scientists can attain a comprehensive snapshot of viral circulation without infringing on individual privacy or requiring invasive testing. Dr. Justin Clark, an assistant professor at Baylor, remarks that this environmental surveillance circumvents many barriers inherent to clinical diagnostics, yielding population-level insights capable of guiding public health policies more responsively.

The concept of monitoring viral pathogens via wastewater is not new, tracing its origins back over half a century when it was first utilized to detect poliovirus. More recently, during the COVID-19 pandemic, Baylor researchers were instrumental in pioneering wastewater surveillance to track SARS-CoV-2 variants and prevalence, providing invaluable data that anticipated outbreaks and guided healthcare resource allocation. Building on this expertise, the Texas Wastewater and Environmental Biomonitoring (TexWEB) initiative commenced viral genomic sequencing of wastewater from major Texan cities, sampling across a wide geographic and demographic spectrum since mid-2022.

This study employs a cutting-edge hybrid-capture genetic sequencing technique, capable of detecting over 3,000 distinct human viruses while simultaneously identifying novel viral mutations. The method enriches viral sequences from wastewater samples and subject them to high-throughput sequencing, generating granular data about virus presence, relative abundance, and evolutionary changes. Harihara Prakash, the study’s first author and bioinformatics analyst, emphasizes that this technology offers unparalleled resolution for viral surveillance within complex environmental samples.

Between May 2022 and May 2025, more than 40 wastewater collection points in 16 Texan cities were sampled, representing roughly 25% of the state’s population. The deep sequencing and computational analyses provide temporal dynamics of viral populations, enabling the team to discern both seasonal fluctuations and long-term trends in oncogenic virus prevalence. These data demonstrate not only viral presence but also shifts in viral dominance and diversity within communities.

All known oncogenic viruses were detected in the analyzed wastewater samples. Among the predominant viruses found were HPV, hepatitis B and C viruses, and human polyomaviruses associated with various cancers. The study further identified Epstein-Barr virus (EBV) and Kaposi’s sarcoma-associated herpesvirus, both implicated in lymphomas and rare blood cancers. This comprehensive detection attests to the robustness of wastewater metagenomics in capturing viral diversity relevant to cancer etiology.

Intriguingly, the data reveal an upward trajectory in the abundance of multiple oncogenic viruses over the three-year study period. Significant surges following 2024 were noted in HPV, EBV, and certain polyomaviruses. The researchers hypothesize that these spikes may correlate with increased social interactions, including seasonal travel and heightened interpersonal contact during academic sessions, coinciding with the relaxation of COVID-19 social distancing mandates. Such epidemiological insights underscore the influence of behavioral and policy changes on viral transmission dynamics.

The team delved deeper into HPV subtype distributions due to its prominent role in cervical and oropharyngeal cancers. Despite the high-risk types being generally less prevalent than low-risk ones, the high-risk strains, particularly HPV-16 and HPV-18, exhibited distinct increasing trends late in the surveillance window. Notably, HPV-16 consistently outnumbered HPV-18 across samples, aligning with global clinical observations about their relative oncogenic burden. These findings underscore the method’s precision in parsing subtype-specific epidemiology from environmental samples.

Critical to public health implementation, the researchers detected all nine HPV genotypes targeted by the Gardasil 9 vaccine, validating wastewater surveillance as a tool to monitor vaccine-preventable oncogenic viruses. This capability holds promise for evaluating vaccine coverage effectiveness and identifying regions where immunization uptake may be insufficient, providing actionable data to optimize vaccination strategies and ultimately reduce virus-induced cancer incidence.

This pioneering research firmly establishes that oncogenic viruses can be tracked non-invasively via wastewater, broadening our capacity to surveil viral cancer risks within populations. By elucidating viral prevalence patterns and their temporal evolution, this approach opens new avenues to design timely and targeted public health interventions. Dr. Maresso stresses the prospective translation of these insights into tangible cancer prevention measures, harnessing environmental virology as an adjunct to traditional clinical epidemiology.

The study’s interdisciplinary team from Baylor College of Medicine and the University of Texas Health Science Center at Houston collectively contributed to this comprehensive effort. With generous funding from multiple state and federal sources, including the Texas Legislature and NIH, the research exemplifies the synergy of innovative technology, bioinformatics, and public health priorities converging to combat virus-associated cancers.

As wastewater metagenomics continues to evolve, its integration with epidemiological modeling and clinical surveillance promises an unprecedented vantage point on community health. This initiative exemplifies how environmental data streams can supplement conventional health monitoring to anticipate viral threats before they culminate in disease, fostering a paradigm shift in preventative oncology and viral epidemiology. The success of this approach embodies a beacon for future efforts, illuminating the potential of wastewater not just as waste but as a rich, real-time source of viral intelligence.

Subject of Research: Human tissue samples

Article Title: Detection, persistence, and rising prevalence of oncogenic viruses revealed by wastewater metagenomics

News Publication Date: 13-May-2026

Web References:

• https://journals.asm.org/eprint/NAW85DPAZMGV9SR2YDHQ/full
• https://tephi.texas.gov/early-detection
• http://dx.doi.org/10.1128/aem.00547-26

References:
Perez RK, Ross M, Tisza M, Javornik Cregeen SJ, Petrosino JF, Deegan J, Boerwinkle E, Maresso AN, Clark J, Prakash H. Detection, persistence, and rising prevalence of oncogenic viruses revealed by wastewater metagenomics. Applied and Environmental Microbiology. 2026; DOI: 10.1128/aem.00547-26.

Keywords: Wastewater surveillance; Oncogenic viruses; Human papillomavirus; Epstein-Barr virus; Polyomaviruses; Viral metagenomics; Public health; Viral epidemiology; Cancer prevention; Hybrid-capture sequencing

Colorectal cancer, traditionally associated with older populations, is now demonstrating a disturbing rise in younger demographics, signaling potentially changing risk factors in diet and lifestyle. The Physicians Committee highlights the critical need for consumer awareness, emphasizing that many Americans remain unaware of the carcinogenic risk tied to processed meat consumption. Anna Herby, a nutrition education specialist with extensive expertise in dietetics, underscores the urgency of clear regulatory action to inform consumers that products regularly deemed “wholesome” by the USDA may, in fact, pose significant cancer risks.

Epidemiological data underpinning these concerns are robust and multifaceted. The American Cancer Society projects that over 150,000 new cases of colorectal cancer will be diagnosed in 2026, alongside more than 55,000 deaths attributed to this malignancy. The dilemma confronts the U.S. regulatory framework, which currently certifies processed meats as fit for human consumption under the Federal Meat Inspection Act and the Poultry Products Inspection Act, despite mounting evidence categorizing these foods as “unhealthful” or “unwholesome” due to their carcinogenic potential.

Expert consensus came to a head in 2015 when the IARC conducted an exhaustive evaluation involving 22 specialists from 10 countries, who synthesized data from over 800 epidemiological studies. Their conclusion was categorical: processed meat consumption increases colorectal cancer risk sufficiently to classify these substances within Group 1 carcinogens—the highest classification reserved for known human carcinogens. Notably, their meta-analysis determined that consuming just 50 grams of processed meat daily—approximately equivalent to one standard hot dog—increases colorectal cancer relative risk by 18%.

Further reinforcing these findings, recent American Cancer Society research published in the Journal of the American Medical Association (JAMA) reveals colorectal cancer mortality rates outpacing those of all other cancers among individuals younger than 50 years. Supplementary studies in Nutrition and Cancer add nuance by delineating a direct correlation between elevated processed meat intake and early-onset colorectal cancer diagnoses, emphasizing the disease’s evolving epidemiology.

Despite this overwhelming scientific evidence, communication gaps persist. A recent poll conducted by the Physicians Committee in collaboration with Morning Consult indicates a significant deficiency in public understanding, with nearly half of Americans unaware of the carcinogenic risks associated with processed meats. Encouragingly, a substantial majority—64%—express support for warning labels that would explicitly disclose the cancer risk associated with these ubiquitous food products.

The petition submitted to the USDA not only spotlights this public health imperative but also challenges the regulatory authorities to reconcile their inspection standards with contemporary scientific knowledge. It argues that the USDA’s designation of “wholesome” is misleading for processed meat and poultry and proposes a label amendment mandating the unequivocal statement: “This product might increase the risk of colorectal cancer.” Such transparency, it is argued, would empower consumers to make more informed dietary choices aligned with cancer prevention.

Biochemical mechanisms underlying the carcinogenicity of processed meats have been the subject of intense research. Compounds such as N-nitroso compounds (NOCs), polycyclic aromatic hydrocarbons (PAHs), and heterocyclic amines (HCAs) generated during processing, curing, and cooking at high temperatures induce DNA damage and inflammatory responses in colonic epithelial cells, fostering tumorigenesis. These mechanistic insights provide a critical link between epidemiological data and molecular pathology, strengthening the causative argument.

Concurrently, public health advocates stress dietary shifts towards increased consumption of fiber-rich plant-based foods, including fruits, vegetables, whole grains, and legumes. Epidemiological and clinical studies indicate that such dietary patterns not only mitigate colorectal cancer risk but also confer broad systemic health benefits, including improved metabolic regulation and reduced inflammation.

This emerging consensus clearly delineates a pressing need for regulatory reforms and enhanced public health messaging. The Physicians Committee’s petition represents a critical step toward bridging the gap between scientific evidence and consumer protection, advocating for regulatory practices that reflect contemporary cancer epidemiology and toxicological findings.

In summary, the growing burden of colorectal cancer among younger populations, combined with the scientifically recognized carcinogenic potential of processed meats, presents an acute challenge for public health policy. Clear, authoritative labeling by the USDA and informed consumer awareness could serve as vital components of a comprehensive cancer prevention strategy in the United States.

Subject of Research: Colorectal cancer risk linked to processed meat and poultry consumption

Article Title: USDA Petition Urges Mandatory Cancer Risk Warning Labels on Processed Meat and Poultry Amid Rising Colorectal Cancer Rates

News Publication Date: No specific date provided in original content

Web References:

• https://pcrm.widen.net/s/v28glxr9gj/physicians-committee-for-responsible-medicine-usda-petition-colorectal-cancer-risk-from-processed-meat-and-poultry

Keywords: colorectal cancer, processed meat, poultry, cancer risk, cancer warning labels, USDA, carcinogenic, International Agency for Research on Cancer, epidemiology, cancer prevention, public health, diet and cancer